Download This PaperA New Market Access Path for Repurposed Drugs
4 Pages Posted: 17 May 2014
Date Written: May 1, 2014
Abstract
A diverse set of stakeholders within health care came together in the fall of 2013 to brainstorm potential new commercial paths for repurposed drugs for the treatment of rare diseases. This report highlights some of the identified solutions that potentially could create the right set of incentives for the efficient and accelerated development and delivery of needed therapies for patients suffering from rare diseases.
Keywords: health care, pharmaceutical, drug, repurpose, innovation
Suggested Citation: Suggested Citation
Pahud, Dominique and Mitchell, Lesa and Wilbanks, John and Stevens, Melissa and Weir, Scott and McBride, John and Portilla, Lili and Pezalla, Ed and Nameth, Michael and O'Donoghue, Bernadette and Rai, Arti Kaur and Lappin, Debra and Ogle, Mary and Howell, Scott, A New Market Access Path for Repurposed Drugs (May 1, 2014). Available at SSRN: https://ssrn.com/abstract=2437502 or http://dx.doi.org/10.2139/ssrn.2437502
Duke Innovation & Entrepreneurship Initiative ( email )
215 Morris St., Suite 300
Durham, NC 27701
United States
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.